Selected research
Industry Research
Venous Disease Interventional Therapy Industry Research Report 2026
Market perspective
The global Venous Disease Interventional Therapy market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Venous Disease Interventional Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Venous Disease Interventional Therapy is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Venous Disease Interventional Therapy is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Venous Disease Interventional Therapy include Argon Medical Devices, Arjo, BD, Braile BIOMEDICA, Breg, Cardinal Health, Cook Medical, Cordis and Philips, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Venous Disease Interventional Therapy market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Venous Disease Interventional Therapy Market by Company
Argon Medical Devices
Arjo
BD
Braile BIOMEDICA
Breg
Cardinal Health
Cook Medical
Cordis
Philips
Rex Medical
Zimmer Biomet
B. Braun
Boston Scientific
Zylox-Tonbridge Medical Technology
Medtronic
Suzhou Tianhong Shengjie Medical Equipment
Shandong Visee Medical Devices
LifeTech Scientific
Acotec Scientific Holdings
Shanghai MicroPort Endovascular MedTech
Abbott
Venous Disease Interventional Therapy Segment by Type
Varicose Veins
Iliac Vein Compression
Deep vein Thrombosis
Venous Disease Interventional Therapy Segment by Application
Hospital
Clinic
Venous Disease Interventional Therapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Venous Disease Interventional Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Venous Disease Interventional Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Venous Disease Interventional Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Venous Disease Interventional Therapy manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Venous Disease Interventional Therapy by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Venous Disease Interventional Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Venous Disease Interventional Therapy Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Venous Disease Interventional Therapy Sales (K Units) of Manufacturers (2021-2026)
Table 7. Global Venous Disease Interventional Therapy Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Venous Disease Interventional Therapy Revenue of Manufacturers (2021-2026)
Table 9. Global Venous Disease Interventional Therapy Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Venous Disease Interventional Therapy Average Price (US$/Unit) of Manufacturers (2021-2026)
Table 11. Global Venous Disease Interventional Therapy Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Venous Disease Interventional Therapy, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Venous Disease Interventional Therapy, Product Type & Application
Table 14. Global Venous Disease Interventional Therapy Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Venous Disease Interventional Therapy by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Argon Medical Devices Company Information
Table 19. Argon Medical Devices Business Overview
Table 20. Argon Medical Devices Venous Disease Interventional Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 21. Argon Medical Devices Venous Disease Interventional Therapy Product Portfolio
Table 22. Argon Medical Devices Recent Developments
Table 23. Arjo Company Information
Table 24. Arjo Business Overview
Table 25. Arjo Venous Disease Interventional Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 26. Arjo Venous Disease Interventional Therapy Product Portfolio
Table 27. Arjo Recent Developments
Table 28. BD Company Information
Table 29. BD Business Overview
Table 30. BD Venous Disease Interventional Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 31. BD Venous Disease Interventional Therapy Product Portfolio
Table 32. BD Recent Developments
Table 33. Braile BIOMEDICA Company Information
Table 34. Braile BIOMEDICA Business Overview
Table 35. Braile BIOMEDICA Venous Disease Interventional Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 36. Braile BIOMEDICA Venous Disease Interventional Therapy Product Portfolio
Table 37. Braile BIOMEDICA Recent Developments
Table 38. Breg Company Information
Table 39. Breg Business Overview
Table 40. Breg Venous Disease Interventional Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 41. Breg Venous Disease Interventional Therapy Product Portfolio
Table 42. Breg Recent Developments
Table 43. Cardinal Health Company Information
Table 44. Cardinal Health Business Overview
Table 45. Cardinal Health Venous Disease Interventional Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 46. Cardinal Health Venous Disease Interventional Therapy Product Portfolio
Table 47. Cardinal Health Recent Developments
Table 48. Cook Medical Company Information
Table 49. Cook Medical Business Overview
Table 50. Cook Medical Venous Disease Interventional Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 51. Cook Medical Venous Disease Interventional Therapy Product Portfolio
Table 52. Cook Medical Recent Developments
Table 53. Cordis Company Information
Table 54. Cordis Business Overview
Table 55. Cordis Venous Disease Interventional Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 56. Cordis Venous Disease Interventional Therapy Product Portfolio
Table 57. Cordis Recent Developments
Table 58. Philips Company Information
Table 59. Philips Business Overview
Table 60. Philips Venous Disease Interventional Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 61. Philips Venous Disease Interventional Therapy Product Portfolio
Table 62. Philips Recent Developments
Table 63. Rex Medical Company Information
Table 64. Rex Medical Business Overview
Table 65. Rex Medical Venous Disease Interventional Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 66. Rex Medical Venous Disease Interventional Therapy Product Portfolio
Table 67. Rex Medical Recent Developments
Table 68. Zimmer Biomet Company Information
Table 69. Zimmer Biomet Business Overview
Table 70. Zimmer Biomet Venous Disease Interventional Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 71. Zimmer Biomet Venous Disease Interventional Therapy Product Portfolio
Table 72. Zimmer Biomet Recent Developments
Table 73. B. Braun Company Information
Table 74. B. Braun Business Overview
Table 75. B. Braun Venous Disease Interventional Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. B. Braun Venous Disease Interventional Therapy Product Portfolio
Table 77. B. Braun Recent Developments
Table 78. Boston Scientific Company Information
Table 79. Boston Scientific Business Overview
Table 80. Boston Scientific Venous Disease Interventional Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Boston Scientific Venous Disease Interventional Therapy Product Portfolio
Table 82. Boston Scientific Recent Developments
Table 83. Zylox-Tonbridge Medical Technology Company Information
Table 84. Zylox-Tonbridge Medical Technology Business Overview
Table 85. Zylox-Tonbridge Medical Technology Venous Disease Interventional Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Zylox-Tonbridge Medical Technology Venous Disease Interventional Therapy Product Portfolio
Table 87. Zylox-Tonbridge Medical Technology Recent Developments
Table 88. Medtronic Company Information
Table 89. Medtronic Business Overview
Table 90. Medtronic Venous Disease Interventional Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Medtronic Venous Disease Interventional Therapy Product Portfolio
Table 92. Medtronic Recent Developments
Table 93. Suzhou Tianhong Shengjie Medical Equipment Company Information
Table 94. Suzhou Tianhong Shengjie Medical Equipment Business Overview
Table 95. Suzhou Tianhong Shengjie Medical Equipment Venous Disease Interventional Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Suzhou Tianhong Shengjie Medical Equipment Venous Disease Interventional Therapy Product Portfolio
Table 97. Suzhou Tianhong Shengjie Medical Equipment Recent Developments
Table 98. Shandong Visee Medical Devices Company Information
Table 99. Shandong Visee Medical Devices Business Overview
Table 100. Shandong Visee Medical Devices Venous Disease Interventional Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Shandong Visee Medical Devices Venous Disease Interventional Therapy Product Portfolio
Table 102. Shandong Visee Medical Devices Recent Developments
Table 103. LifeTech Scientific Company Information
Table 104. LifeTech Scientific Business Overview
Table 105. LifeTech Scientific Venous Disease Interventional Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. LifeTech Scientific Venous Disease Interventional Therapy Product Portfolio
Table 107. LifeTech Scientific Recent Developments
Table 108. Acotec Scientific Holdings Company Information
Table 109. Acotec Scientific Holdings Business Overview
Table 110. Acotec Scientific Holdings Venous Disease Interventional Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Acotec Scientific Holdings Venous Disease Interventional Therapy Product Portfolio
Table 112. Acotec Scientific Holdings Recent Developments
Table 113. Shanghai MicroPort Endovascular MedTech Company Information
Table 114. Shanghai MicroPort Endovascular MedTech Business Overview
Table 115. Shanghai MicroPort Endovascular MedTech Venous Disease Interventional Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Shanghai MicroPort Endovascular MedTech Venous Disease Interventional Therapy Product Portfolio
Table 117. Shanghai MicroPort Endovascular MedTech Recent Developments
Table 118. Abbott Company Information
Table 119. Abbott Business Overview
Table 120. Abbott Venous Disease Interventional Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Abbott Venous Disease Interventional Therapy Product Portfolio
Table 122. Abbott Recent Developments
Table 123. Global Venous Disease Interventional Therapy Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 124. Global Venous Disease Interventional Therapy Sales by Region (2021-2026) & (K Units)
Table 125. Global Venous Disease Interventional Therapy Sales Market Share by Region (2021-2026)
Table 126. Global Venous Disease Interventional Therapy Sales by Region (2027-2032) & (K Units)
Table 127. Global Venous Disease Interventional Therapy Sales Market Share by Region (2027-2032)
Table 128. Global Venous Disease Interventional Therapy Revenue by Region (2021-2026) & (US$ Million)
Table 129. Global Venous Disease Interventional Therapy Revenue Market Share by Region (2021-2026)
Table 130. Global Venous Disease Interventional Therapy Revenue by Region (2027-2032) & (US$ Million)
Table 131. Global Venous Disease Interventional Therapy Revenue Market Share by Region (2027-2032)
Table 132. North America Venous Disease Interventional Therapy Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 133. North America Venous Disease Interventional Therapy Sales by Country (2021-2026) & (K Units)
Table 134. North America Venous Disease Interventional Therapy Sales by Country (2027-2032) & (K Units)
Table 135. North America Venous Disease Interventional Therapy Revenue by Country (2021-2026) & (US$ Million)
Table 136. North America Venous Disease Interventional Therapy Revenue by Country (2027-2032) & (US$ Million)
Table 137. Europe Venous Disease Interventional Therapy Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 138. Europe Venous Disease Interventional Therapy Sales by Country (2021-2026) & (K Units)
Table 139. Europe Venous Disease Interventional Therapy Sales by Country (2027-2032) & (K Units)
Table 140. Europe Venous Disease Interventional Therapy Revenue by Country (2021-2026) & (US$ Million)
Table 141. Europe Venous Disease Interventional Therapy Revenue by Country (2027-2032) & (US$ Million)
Table 142. Asia Pacific Venous Disease Interventional Therapy Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 143. Asia Pacific Venous Disease Interventional Therapy Sales by Country (2021-2026) & (K Units)
Table 144. Asia Pacific Venous Disease Interventional Therapy Sales by Country (2027-2032) & (K Units)
Table 145. Asia Pacific Venous Disease Interventional Therapy Revenue by Country (2021-2026) & (US$ Million)
Table 146. Asia Pacific Venous Disease Interventional Therapy Revenue by Country (2027-2032) & (US$ Million)
Table 147. South America Venous Disease Interventional Therapy Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 148. South America Venous Disease Interventional Therapy Sales by Country (2021-2026) & (K Units)
Table 149. South America Venous Disease Interventional Therapy Sales by Country (2027-2032) & (K Units)
Table 150. South America Venous Disease Interventional Therapy Revenue by Country (2021-2026) & (US$ Million)
Table 151. South America Venous Disease Interventional Therapy Revenue by Country (2027-2032) & (US$ Million)
Table 152. Middle East and Africa Venous Disease Interventional Therapy Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 153. Middle East and Africa Venous Disease Interventional Therapy Sales by Country (2021-2026) & (K Units)
Table 154. Middle East and Africa Venous Disease Interventional Therapy Sales by Country (2027-2032) & (K Units)
Table 155. Middle East and Africa Venous Disease Interventional Therapy Revenue by Country (2021-2026) & (US$ Million)
Table 156. Middle East and Africa Venous Disease Interventional Therapy Revenue by Country (2027-2032) & (US$ Million)
Table 157. Global Venous Disease Interventional Therapy Sales by Type (2021-2026) & (K Units)
Table 158. Global Venous Disease Interventional Therapy Sales by Type (2027-2032) & (K Units)
Table 159. Global Venous Disease Interventional Therapy Sales Market Share by Type (2021-2026)
Table 160. Global Venous Disease Interventional Therapy Sales Market Share by Type (2027-2032)
Table 161. Global Venous Disease Interventional Therapy Revenue by Type (2021-2026) & (US$ Million)
Table 162. Global Venous Disease Interventional Therapy Revenue by Type (2027-2032) & (US$ Million)
Table 163. Global Venous Disease Interventional Therapy Revenue Market Share by Type (2021-2026)
Table 164. Global Venous Disease Interventional Therapy Revenue Market Share by Type (2027-2032)
Table 165. Global Venous Disease Interventional Therapy Price by Type (2021-2026) & (US$/Unit)
Table 166. Global Venous Disease Interventional Therapy Price by Type (2027-2032) & (US$/Unit)
Table 167. Global Venous Disease Interventional Therapy Sales by Application (2021-2026) & (K Units)
Table 168. Global Venous Disease Interventional Therapy Sales by Application (2027-2032) & (K Units)
Table 169. Global Venous Disease Interventional Therapy Sales Market Share by Application (2021-2026)
Table 170. Global Venous Disease Interventional Therapy Sales Market Share by Application (2027-2032)
Table 171. Global Venous Disease Interventional Therapy Revenue by Application (2021-2026) & (US$ Million)
Table 172. Global Venous Disease Interventional Therapy Revenue by Application (2027-2032) & (US$ Million)
Table 173. Global Venous Disease Interventional Therapy Revenue Market Share by Application (2021-2026)
Table 174. Global Venous Disease Interventional Therapy Revenue Market Share by Application (2027-2032)
Table 175. Global Venous Disease Interventional Therapy Price by Application (2021-2026) & (US$/Unit)
Table 176. Global Venous Disease Interventional Therapy Price by Application (2027-2032) & (US$/Unit)
Table 177. Key Raw Materials
Table 178. Raw Materials Key Suppliers
Table 179. Venous Disease Interventional Therapy Distributors List
Table 180. Venous Disease Interventional Therapy Customers List
Table 181. Venous Disease Interventional Therapy Industry Trends
Table 182. Venous Disease Interventional Therapy Industry Drivers
Table 183. Venous Disease Interventional Therapy Industry Restraints
Table 184. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Venous Disease Interventional Therapy Product Image
Figure 5. Global Venous Disease Interventional Therapy Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Venous Disease Interventional Therapy Market Size (2021-2032) & (US$ Million)
Figure 7. Global Venous Disease Interventional Therapy Sales (2021-2032) & (K Units)
Figure 8. Global Venous Disease Interventional Therapy Average Price (US$/Unit) & (2021-2032)
Figure 9. Varicose Veins Product Image
Figure 10. Iliac Vein Compression Product Image
Figure 11. Deep vein Thrombosis Product Image
Figure 12. Hospital Product Image
Figure 13. Clinic Product Image
Figure 14. Global Venous Disease Interventional Therapy Revenue Share by Manufacturers in 2025
Figure 15. Global Manufacturers of Venous Disease Interventional Therapy, Manufacturing Sites & Headquarters
Figure 16. Global Top 5 and 10 Venous Disease Interventional Therapy Players Market Share by Revenue in 2025
Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 18. Global Venous Disease Interventional Therapy Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 19. Global Venous Disease Interventional Therapy Sales by Region in 2025
Figure 20. Global Venous Disease Interventional Therapy Revenue by Region in 2025
Figure 21. North America Venous Disease Interventional Therapy Market Size by Country in 2025
Figure 22. North America Venous Disease Interventional Therapy Sales Market Share by Country (2021-2032)
Figure 23. North America Venous Disease Interventional Therapy Revenue Market Share by Country (2021-2032)
Figure 24. United States Venous Disease Interventional Therapy Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 25. Canada Venous Disease Interventional Therapy Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 26. Mexico Venous Disease Interventional Therapy Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 27. Europe Venous Disease Interventional Therapy Market Size by Country in 2025
Figure 28. Europe Venous Disease Interventional Therapy Sales Market Share by Country (2021-2032)
Figure 29. Europe Venous Disease Interventional Therapy Revenue Market Share by Country (2021-2032)
Figure 30. Germany Venous Disease Interventional Therapy Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 31. France Venous Disease Interventional Therapy Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. U.K. Venous Disease Interventional Therapy Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. Italy Venous Disease Interventional Therapy Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. Russia Venous Disease Interventional Therapy Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Spain Venous Disease Interventional Therapy Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. Netherlands Venous Disease Interventional Therapy Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. Switzerland Venous Disease Interventional Therapy Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Sweden Venous Disease Interventional Therapy Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Poland Venous Disease Interventional Therapy Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. Asia Pacific Venous Disease Interventional Therapy Market Size by Country in 2025
Figure 41. Asia Pacific Venous Disease Interventional Therapy Sales Market Share by Country (2021-2032)
Figure 42. Asia Pacific Venous Disease Interventional Therapy Revenue Market Share by Country (2021-2032)
Figure 43. China Venous Disease Interventional Therapy Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 44. Japan Venous Disease Interventional Therapy Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. South Korea Venous Disease Interventional Therapy Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. India Venous Disease Interventional Therapy Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 47. Australia Venous Disease Interventional Therapy Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 48. Taiwan Venous Disease Interventional Therapy Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. Southeast Asia Venous Disease Interventional Therapy Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Southeast Asia Venous Disease Interventional Therapy Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. South America Venous Disease Interventional Therapy Market Size by Country in 2025
Figure 52. South America Venous Disease Interventional Therapy Sales Market Share by Country (2021-2032)
Figure 53. South America Venous Disease Interventional Therapy Revenue Market Share by Country (2021-2032)
Figure 54. Brazil Venous Disease Interventional Therapy Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 55. Argentina Venous Disease Interventional Therapy Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 56. Chile Venous Disease Interventional Therapy Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. Middle East and Africa Venous Disease Interventional Therapy Market Size by Country in 2025
Figure 58. Middle East and Africa Venous Disease Interventional Therapy Sales Market Share by Country (2021-2032)
Figure 59. Middle East and Africa Venous Disease Interventional Therapy Revenue Market Share by Country (2021-2032)
Figure 60. Egypt Venous Disease Interventional Therapy Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 61. South Africa Venous Disease Interventional Therapy Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 62. Israel Venous Disease Interventional Therapy Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 63. Türkiye Venous Disease Interventional Therapy Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 64. GCC Countries Venous Disease Interventional Therapy Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 65. Global Venous Disease Interventional Therapy Sales Market Share by Type (2021-2032)
Figure 66. Global Venous Disease Interventional Therapy Revenue Market Share by Type (2021-2032)
Figure 67. Global Venous Disease Interventional Therapy Price (US$/Unit) by Type (2021-2032)
Figure 68. Global Venous Disease Interventional Therapy Sales Market Share by Application (2021-2032)
Figure 69. Global Venous Disease Interventional Therapy Revenue Market Share by Application (2021-2032)
Figure 70. Global Venous Disease Interventional Therapy Price (US$/Unit) by Application (2021-2032)
Figure 71. Venous Disease Interventional Therapy Value Chain
Figure 72. Venous Disease Interventional Therapy Production Mode & Process
Figure 73. Direct Comparison with Distribution Share
Figure 74. Distributors Profiles
Figure 75. Venous Disease Interventional Therapy Industry Opportunities and Challenges
Scope & coverage.
Types
- Varicose Veins
- Iliac Vein Compression
- Deep vein Thrombosis
Applications
- Hospital
- Clinic
Companies covered
- Argon Medical Devices
- Arjo
- BD
- Braile BIOMEDICA
- Breg
- Cardinal Health
- Cook Medical
- Cordis
- Philips
- Rex Medical
- Zimmer Biomet
- B. Braun
- Boston Scientific
- Zylox-Tonbridge Medical Technology
- Medtronic
- Suzhou Tianhong Shengjie Medical Equipment
- Shandong Visee Medical Devices
- LifeTech Scientific
- Acotec Scientific Holdings
- Shanghai MicroPort Endovascular MedTech
- Abbott
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Venous Disease Interventional Therapy Market Size (2021-2032)
- 2.2.2 Global Venous Disease Interventional Therapy Sales (2021-2032)
- 2.2.3 Global Venous Disease Interventional Therapy Market Average Price (2021-2032)
- 2.3 Venous Disease Interventional Therapy by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Varicose Veins
- 2.3.3 Iliac Vein Compression
- 2.3.4 Deep vein Thrombosis
- 2.4 Venous Disease Interventional Therapy by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Venous Disease Interventional Therapy Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Venous Disease Interventional Therapy Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Venous Disease Interventional Therapy Revenue of Manufacturers (2021-2026)
- 3.4 Global Venous Disease Interventional Therapy Average Price by Manufacturers (2021-2026)
- 3.5 Global Venous Disease Interventional Therapy Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Venous Disease Interventional Therapy, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Venous Disease Interventional Therapy, Product Type & Application
- 3.8 Global Manufacturers of Venous Disease Interventional Therapy, Established Date
- 3.9 Global Venous Disease Interventional Therapy Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Argon Medical Devices
- 4.1.1 Argon Medical Devices Company Information
- 4.1.2 Argon Medical Devices Business Overview
- 4.1.3 Argon Medical Devices Venous Disease Interventional Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Argon Medical Devices Venous Disease Interventional Therapy Product Portfolio
- 4.1.5 Argon Medical Devices Recent Developments
- 4.2 Arjo
- 4.2.1 Arjo Company Information
- 4.2.2 Arjo Business Overview
- 4.2.3 Arjo Venous Disease Interventional Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Arjo Venous Disease Interventional Therapy Product Portfolio
- 4.2.5 Arjo Recent Developments
- 4.3 BD
- 4.3.1 BD Company Information
- 4.3.2 BD Business Overview
- 4.3.3 BD Venous Disease Interventional Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 BD Venous Disease Interventional Therapy Product Portfolio
- 4.3.5 BD Recent Developments
- 4.4 Braile BIOMEDICA
- 4.4.1 Braile BIOMEDICA Company Information
- 4.4.2 Braile BIOMEDICA Business Overview
- 4.4.3 Braile BIOMEDICA Venous Disease Interventional Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Braile BIOMEDICA Venous Disease Interventional Therapy Product Portfolio
- 4.4.5 Braile BIOMEDICA Recent Developments
- 4.5 Breg
- 4.5.1 Breg Company Information
- 4.5.2 Breg Business Overview
- 4.5.3 Breg Venous Disease Interventional Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Breg Venous Disease Interventional Therapy Product Portfolio
- 4.5.5 Breg Recent Developments
- 4.6 Cardinal Health
- 4.6.1 Cardinal Health Company Information
- 4.6.2 Cardinal Health Business Overview
- 4.6.3 Cardinal Health Venous Disease Interventional Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Cardinal Health Venous Disease Interventional Therapy Product Portfolio
- 4.6.5 Cardinal Health Recent Developments
- 4.7 Cook Medical
- 4.7.1 Cook Medical Company Information
- 4.7.2 Cook Medical Business Overview
- 4.7.3 Cook Medical Venous Disease Interventional Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Cook Medical Venous Disease Interventional Therapy Product Portfolio
- 4.7.5 Cook Medical Recent Developments
- 4.8 Cordis
- 4.8.1 Cordis Company Information
- 4.8.2 Cordis Business Overview
- 4.8.3 Cordis Venous Disease Interventional Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Cordis Venous Disease Interventional Therapy Product Portfolio
- 4.8.5 Cordis Recent Developments
- 4.9 Philips
- 4.9.1 Philips Company Information
- 4.9.2 Philips Business Overview
- 4.9.3 Philips Venous Disease Interventional Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Philips Venous Disease Interventional Therapy Product Portfolio
- 4.9.5 Philips Recent Developments
- 4.10 Rex Medical
- 4.10.1 Rex Medical Company Information
- 4.10.2 Rex Medical Business Overview
- 4.10.3 Rex Medical Venous Disease Interventional Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Rex Medical Venous Disease Interventional Therapy Product Portfolio
- 4.10.5 Rex Medical Recent Developments
- 4.11 Zimmer Biomet
- 4.11.1 Zimmer Biomet Company Information
- 4.11.2 Zimmer Biomet Business Overview
- 4.11.3 Zimmer Biomet Venous Disease Interventional Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Zimmer Biomet Venous Disease Interventional Therapy Product Portfolio
- 4.11.5 Zimmer Biomet Recent Developments
- 4.12 B. Braun
- 4.12.1 B. Braun Company Information
- 4.12.2 B. Braun Business Overview
- 4.12.3 B. Braun Venous Disease Interventional Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 B. Braun Venous Disease Interventional Therapy Product Portfolio
- 4.12.5 B. Braun Recent Developments
- 4.13 Boston Scientific
- 4.13.1 Boston Scientific Company Information
- 4.13.2 Boston Scientific Business Overview
- 4.13.3 Boston Scientific Venous Disease Interventional Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Boston Scientific Venous Disease Interventional Therapy Product Portfolio
- 4.13.5 Boston Scientific Recent Developments
- 4.14 Zylox-Tonbridge Medical Technology
- 4.14.1 Zylox-Tonbridge Medical Technology Company Information
- 4.14.2 Zylox-Tonbridge Medical Technology Business Overview
- 4.14.3 Zylox-Tonbridge Medical Technology Venous Disease Interventional Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Zylox-Tonbridge Medical Technology Venous Disease Interventional Therapy Product Portfolio
- 4.14.5 Zylox-Tonbridge Medical Technology Recent Developments
- 4.15 Medtronic
- 4.15.1 Medtronic Company Information
- 4.15.2 Medtronic Business Overview
- 4.15.3 Medtronic Venous Disease Interventional Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Medtronic Venous Disease Interventional Therapy Product Portfolio
- 4.15.5 Medtronic Recent Developments
- 4.16 Suzhou Tianhong Shengjie Medical Equipment
- 4.16.1 Suzhou Tianhong Shengjie Medical Equipment Company Information
- 4.16.2 Suzhou Tianhong Shengjie Medical Equipment Business Overview
- 4.16.3 Suzhou Tianhong Shengjie Medical Equipment Venous Disease Interventional Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Suzhou Tianhong Shengjie Medical Equipment Venous Disease Interventional Therapy Product Portfolio
- 4.16.5 Suzhou Tianhong Shengjie Medical Equipment Recent Developments
- 4.17 Shandong Visee Medical Devices
- 4.17.1 Shandong Visee Medical Devices Company Information
- 4.17.2 Shandong Visee Medical Devices Business Overview
- 4.17.3 Shandong Visee Medical Devices Venous Disease Interventional Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Shandong Visee Medical Devices Venous Disease Interventional Therapy Product Portfolio
- 4.17.5 Shandong Visee Medical Devices Recent Developments
- 4.18 LifeTech Scientific
- 4.18.1 LifeTech Scientific Company Information
- 4.18.2 LifeTech Scientific Business Overview
- 4.18.3 LifeTech Scientific Venous Disease Interventional Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 LifeTech Scientific Venous Disease Interventional Therapy Product Portfolio
- 4.18.5 LifeTech Scientific Recent Developments
- 4.19 Acotec Scientific Holdings
- 4.19.1 Acotec Scientific Holdings Company Information
- 4.19.2 Acotec Scientific Holdings Business Overview
- 4.19.3 Acotec Scientific Holdings Venous Disease Interventional Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Acotec Scientific Holdings Venous Disease Interventional Therapy Product Portfolio
- 4.19.5 Acotec Scientific Holdings Recent Developments
- 4.20 Shanghai MicroPort Endovascular MedTech
- 4.20.1 Shanghai MicroPort Endovascular MedTech Company Information
- 4.20.2 Shanghai MicroPort Endovascular MedTech Business Overview
- 4.20.3 Shanghai MicroPort Endovascular MedTech Venous Disease Interventional Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.20.4 Shanghai MicroPort Endovascular MedTech Venous Disease Interventional Therapy Product Portfolio
- 4.20.5 Shanghai MicroPort Endovascular MedTech Recent Developments
- 4.21 Abbott
- 4.21.1 Abbott Company Information
- 4.21.2 Abbott Business Overview
- 4.21.3 Abbott Venous Disease Interventional Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.21.4 Abbott Venous Disease Interventional Therapy Product Portfolio
- 4.21.5 Abbott Recent Developments
5 Global Venous Disease Interventional Therapy Market Scenario by Region
- 5.1 Global Venous Disease Interventional Therapy Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Venous Disease Interventional Therapy Sales by Region: 2021-2032
- 5.2.1 Global Venous Disease Interventional Therapy Sales by Region: 2021-2026
- 5.2.2 Global Venous Disease Interventional Therapy Sales by Region: 2027-2032
- 5.3 Global Venous Disease Interventional Therapy Revenue by Region: 2021-2032
- 5.3.1 Global Venous Disease Interventional Therapy Revenue by Region: 2021-2026
- 5.3.2 Global Venous Disease Interventional Therapy Revenue by Region: 2027-2032
- 5.4 North America Venous Disease Interventional Therapy Market Facts & Figures by Country
- 5.4.1 North America Venous Disease Interventional Therapy Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Venous Disease Interventional Therapy Sales by Country (2021-2032)
- 5.4.3 North America Venous Disease Interventional Therapy Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Venous Disease Interventional Therapy Market Facts & Figures by Country
- 5.5.1 Europe Venous Disease Interventional Therapy Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Venous Disease Interventional Therapy Sales by Country (2021-2032)
- 5.5.3 Europe Venous Disease Interventional Therapy Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Venous Disease Interventional Therapy Market Facts & Figures by Country
- 5.6.1 Asia Pacific Venous Disease Interventional Therapy Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Venous Disease Interventional Therapy Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Venous Disease Interventional Therapy Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Venous Disease Interventional Therapy Market Facts & Figures by Country
- 5.7.1 South America Venous Disease Interventional Therapy Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Venous Disease Interventional Therapy Sales by Country (2021-2032)
- 5.7.3 South America Venous Disease Interventional Therapy Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Venous Disease Interventional Therapy Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Venous Disease Interventional Therapy Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Venous Disease Interventional Therapy Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Venous Disease Interventional Therapy Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Venous Disease Interventional Therapy Sales by Type (2021-2032)
- 6.1.1 Global Venous Disease Interventional Therapy Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Venous Disease Interventional Therapy Sales Market Share by Type (2021-2032)
- 6.2 Global Venous Disease Interventional Therapy Revenue by Type (2021-2032)
- 6.2.1 Global Venous Disease Interventional Therapy Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Venous Disease Interventional Therapy Revenue Market Share by Type (2021-2032)
- 6.3 Global Venous Disease Interventional Therapy Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Venous Disease Interventional Therapy Sales by Application (2021-2032)
- 7.1.1 Global Venous Disease Interventional Therapy Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Venous Disease Interventional Therapy Sales Market Share by Application (2021-2032)
- 7.2 Global Venous Disease Interventional Therapy Revenue by Application (2021-2032)
- 7.2.1 Global Venous Disease Interventional Therapy Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Venous Disease Interventional Therapy Revenue Market Share by Application (2021-2032)
- 7.3 Global Venous Disease Interventional Therapy Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Venous Disease Interventional Therapy Value Chain Analysis
- 8.1.1 Venous Disease Interventional Therapy Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Venous Disease Interventional Therapy Production Mode & Process
- 8.2 Venous Disease Interventional Therapy Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Venous Disease Interventional Therapy Distributors
- 8.2.3 Venous Disease Interventional Therapy Customers
9 Global Venous Disease Interventional Therapy Analyzing Market Dynamics
- 9.1 Venous Disease Interventional Therapy Industry Trends
- 9.2 Venous Disease Interventional Therapy Industry Drivers
- 9.3 Venous Disease Interventional Therapy Industry Opportunities and Challenges
- 9.4 Venous Disease Interventional Therapy Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst